This meeting will enable delegates to explore new drug discovery science and clinical developments in the field of pain therapeutics. Experts will lead a discussion about ways to approach the challenges of clinical trial design and conduct.
News - Events
This year's event will focus on four themes relating to the management of highly potent active pharmaceutical ingredients. These are: best practice for toxicological assessment; innovations in containment and facility design; advances in the use of robotics and automation in the manufacturing process; and environmental considerations.
This virtual conference will bring together experts in microbiology to discuss innovations in preventing contamination in the manufacture of pharmaceuticals. Conference sessions will cover alternative methods for endotoxin testing and rapid mycoplasma testing, as well as the implementation of in-line bio-burden monitoring to control water systems. A significant part of the conference will focus on contamination control strategies. There will also be a regulatory session discussing objectionable organisms in non-sterile drug products.
The aseptic processing industry, or the processing and packaging of a sterile product, has seen many changes. These are due to advances in manufacturing technology and the use of robotics and automation, to name a few aspects. In 2018, the global aseptic processing market was valued at more than $56 trillion. Revenue is expected to increase to around $124 trillion by 2027. The industry continues to adapt to innovative therapies and to demands to deliver treatments to patients faster. This meeting will examine the new technologies and how they will affect the industry.
This two-day conference will bring together representatives of the pharmaceutical and biotechnology industries and academic institutions to provide first-hand information on the latest oligonucleotide clinical candidates. It will also act as a platform for exchanging ideas on one of the biggest challenges facing the industry: how to deliver these new therapies.
This meeting will provide new information on the potential connectivity and software for medical devices and how these devices can be worn during clinical trials. Key regulatory updates and guidance will also be presented by regulatory, notified body and industry experts. The meeting will give a comprehensive outlook for this expanding field.